文献
J-GLOBAL ID:201702260175879005
整理番号:17A0519301
ビルダグリプチンの有り無しでの強化インスリン療法で治療される2型糖尿病患者におけるカイロミクロン代謝に対する血糖管理の影響と血漿グルコースおよびカイロミクロンの食後代謝の間の相関
Effect of Glycemic Control on Chylomicron Metabolism and Correlation between Postprandial Metabolism of Plasma Glucose and Chylomicron in Patients with Type 2 Diabetes Treated with Basal-bolus Insulin Therapy with or without Vildagliptin
著者 (6件):
Okajima Fumitaka
(Division of Endocrinology, Department of Medicine, Chiba-Hokusoh Hospital, Nippon Medical School)
,
Okajima Fumitaka
(Department of Endocrinology, Diabetes and Metabolism, Graduate School of Medicine, Nippon Medical School)
,
Emoto Naoya
(Division of Endocrinology, Department of Medicine, Chiba-Hokusoh Hospital, Nippon Medical School)
,
Emoto Naoya
(Department of Endocrinology, Diabetes and Metabolism, Graduate School of Medicine, Nippon Medical School)
,
Kato Katsuhito
(Department of Cardiology, Chiba Hokusoh Hospital, Nippon Medical School)
,
Sugihara Hitoshi
(Department of Endocrinology, Diabetes and Metabolism, Graduate School of Medicine, Nippon Medical School)
資料名:
Journal of Atherosclerosis and Thrombosis (Web)
(Journal of Atherosclerosis and Thrombosis (Web))
巻:
24
号:
2
ページ:
157-168(J-STAGE)
発行年:
2017年
JST資料番号:
U0153A
ISSN:
1880-3873
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
日本 (JPN)
言語:
英語 (EN)